Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Let's go

<< Previous

Bullboard Posts

Next >>

Comment by forhandlarenon Dec 10, 2023 2:26pm

101 Views

Post# 35776963

RE:RE:Let's go

Early November
Update Coming Soon was notified

Recently
The short term negative anti-viral in-vitro test was silently published as a stand-alone NR instead as a tail on another NR

This Friday
A promo was published on X that will be the message on top when investors start to garher information about the company.

The nature of the promo lead me into speculation of a NR with the Update back to back.

Any thoughts?

<< Previous

Bullboard Posts

Next >>

Pinnacle Silver & Gold: A promising precious metals investment